Atossa Therapeutics
ATOS
#10748
Rank
S$25.53 M
Marketcap
S$2.56
Share price
1.28%
Change (1 day)
149.46%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): S-$5.26

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is S-$5.27. In 2025 the company made an earnings per share (EPS) of S-$5.21 a decrease over its 2024 EPS that were of S-$3.92.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$5.260.91%
2025S-$5.2132.89%
2024S-$3.92-15.56%
2023S-$4.6414.29%
2022S-$4.0616.67%
2021S-$3.48-90.86%
2020S-$38.09-2.96%
2019S-$39.25-63.09%
2018S-$106.34-49.63%
2017S-$211.14-57.87%
2016S-$501.18-74.01%
2015S-$1,928-9.18%
2014S-$2,123-12.86%
2013S-$2,43670.73%
2012S-$1,42734.07%
2011S-$1,064263.41%
2010S-$292.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$13.12-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$15.82-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
S-$0.32-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S-$0.27-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA